Chennai: People whose immune systems mount an unusually aggressive early response to tuberculosis may be less likely to respond well to standard drug .

Opportunities in the C5 inhibitors market include developing next-gen biosimilars and biosuperiors to improve administration frequency and expand treatment indications for diseases like aHUS, SCD, MG, ...

Meeting the needs of the community is one of North Idaho College President Nick Swayne’s main goals. So when he saw a growing trend toward classical education in the Inland Northwest with charter, ...

A study published in Nature Medicine identified a link between the placebo effect and immune system function. In the experiment, individuals who generated positive expectations showed a stronger ...

Abstract: The construction of the new-type power system has a significant influence on the achievement of “Dual Carbon” goals in both the power system and the whole society. Currently, China is at a ...

A health system–wide lipid screening pathway significantly increased pediatric screening rates across a large primary care network. A structured, system-wide clinical pathway increased pediatric lipid ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

Dysregulated complement pathways are linked to progression from iAMD to advanced AMD, including NVAMD and GA. Higher systemic levels of C4, C4b, and a reduction in C3 are associated with increased ...

Japan now hosts the world’s most advanced quantum–classical hybrid setup, pairing IBM’s cutting-edge quantum system with one of Earth’s fastest supercomputers. On Tuesday, IBM and Japan’s national ...